The induction of an ATP-energized mitochondrial volume change by the combination of the -S-S- compound gliotoxin with either a respiratory inhibitor or an uncoupling agent.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000470:Alkaloids / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000968:Antimycin A / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004220:Disulfides / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D008933:Mitochondrial Swelling; D010101:Oxygen Consumption / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology*
D000470:Alkaloids; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000998:Antiviral Agents; D004140:Dinitrophenols; D004220:Disulfides; D007211:Indoles; D010879:Piperazines; D014475:Uncoupling Agents; D000968:Antimycin A; D000255:Adenosine Triphosphate